Sandoz ‘Surfs The Biosimilars Wave’ Despite US Natalizumab Delay

Although Small-Molecule Sales Are Flat In Q1 Overall, As North American Generics Decline

 
• By David Wallace
  
Surfer riding a wave
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business